Lots of love for midkine in the kidney disease context (biomarker and therapeutic target).
Urine and serum midkine levels in an Australian chronic kidney disease clinic population: an observational study
http://bmjopen.bmj.com/content/7/9/e014615
- Published in print 1 September 2017.
- Published online 27 September 2017.
- Forums
- ASX - By Stock
- AN1
- Publication: Biomarkers Have Higher Diagnostic and Prognostic Potential Than Other Tools
Publication: Biomarkers Have Higher Diagnostic and Prognostic Potential Than Other Tools, page-9
-
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable